Specific COVID-19 Preanalytical Issues Clinical Laboratories Should Consider
Explanation of preanalytical issues with SARS-CoV-2 (COVID-19) testing in clinical laboratories and what to expect in the event of a second wave of infections in the fall.
FDA Issues Warning Letter to KBMO Diagnostics for Advertising Unauthorized At-Home SARS-CoV-2 Testing
Explanation of warnings issued to KBMO Diagnostics related to at-home COVID-19 testing.